allergan inc (AGN:New York Consolidated)
Transactions by ALLERGAN INC (AGN) in the last 6 months
Allergan Inc. (NYSE:AGN) acquired Exemplar Pharma, LLC for less than $20 on April 12, 2013.
Allergan Inc. (NYSE:AGN) entered into a definitive merger agreement to acquire MAP Pharmaceuticals, Inc. (NasdaqGS:MAPP) from a group of shareholders for approximately $960 million on January 22, 2013. The group of shareholders consists of Bay City Capital Fund IV, L.P. managed by Bay City Capital LLC, Skyline Ventures III, L.P. managed by Skyline Ventures, Horizon Technology Finance Management, LLC, T. Rowe Price Associates, Inc., OrbiMed Advisors, L.L.C., FirstMark ...
Bay City Capital LLC
Brookside Capital Management, LLC
Brookside Capital Partners Fund, L.P.
FirstMark Capital, L.L.C.
Horizon Technology Finance Management, LLC
OrbiMed Advisors, L.L.C.
Skyline Ventures III, L.P.
T. Rowe Price Associates, Inc.
|Actavis Inc||$127.23 USD||-0.85|
|Astellas Pharma Inc||¥5,410 JPY||-70.00|
|Regeneron Pharmaceuticals Inc||$250.31 USD||-4.56|
|Shire PLC||2,168 GBp||+34.00|
|Valeant Pharmaceuticals International Inc||C$87.00 CAD||+10.16|
|View Industry Companies|